615 related articles for article (PubMed ID: 20661732)
1. Celiac disease: how complicated can it get?
Tjon JM; van Bergen J; Koning F
Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
[TBL] [Abstract][Full Text] [Related]
2. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
3. Local communication among mucosal immune cells in patients with celiac disease.
van Bergen J; Mulder CJ; Mearin ML; Koning F
Gastroenterology; 2015 May; 148(6):1187-94. PubMed ID: 25623043
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease.
Lionetti E; Catassi C
Dig Liver Dis; 2014 Dec; 46(12):1057-63. PubMed ID: 25200477
[TBL] [Abstract][Full Text] [Related]
5. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
[TBL] [Abstract][Full Text] [Related]
6. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
9. Genes and environment in celiac disease.
Sollid LM; McAdam SN; Molberg O; Quarsten H; Arentz-Hansen H; Louka AS; Lundin KE
Acta Odontol Scand; 2001 Jun; 59(3):183-6. PubMed ID: 11501889
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
Bergseng E; Sidney J; Sette A; Sollid LM
Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
[TBL] [Abstract][Full Text] [Related]
11. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
12. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
[TBL] [Abstract][Full Text] [Related]
13. Pathomechanisms in celiac disease.
Dieterich W; Esslinger B; Schuppan D
Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of celiac disease.
Koning F
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S1-4. PubMed ID: 24979191
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
Nielsen C; Husby S; Lillevang ST
Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
Tollefsen S; Arentz-Hansen H; Fleckenstein B; Molberg O; Ráki M; Kwok WW; Jung G; Lundin KE; Sollid LM
J Clin Invest; 2006 Aug; 116(8):2226-36. PubMed ID: 16878175
[TBL] [Abstract][Full Text] [Related]
17. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
18. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
19. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
